Jakarta - PT Diagnos Laboratory Utama Tbk (DGNS) expects to generate Rp300 billion in revenue this year.

DGNS Corporate Secretary Fanfan Riksani said that to develop the company's business, the company has prepared several development plans, including maximizing examination services or services outside of Covid-19, such as medical check-ups (MCU) examinations related to genetics or genomics.

"In addition to developing new services or services, DGNS also plans to expand new branches and outlet networks. "We intend to open four new branches and establish 10 to 20 outlet networks across Indonesia," he said in a statement issued in Jakarta on Monday (28/3).

Diagnos has planned a capital expenditure (Capex) allocation of around Rp40 billion to maximize the business plan.

DGNS currently has a total of four branches. As for outlets, there are about 30 outlets spread across various regions in Indonesia.